SAIC 10-Q Quarterly Report Nov. 2, 2018 | Alphaminr
Science Applications International Corp

SAIC 10-Q Quarter ended Nov. 2, 2018

SCIENCE APPLICATIONS INTERNATIONAL CORP
10-Ks and 10-Qs
10-Q
Quarter ended Aug. 2, 2024
10-Q
Quarter ended May 3, 2024
10-K
Fiscal year ended Feb. 2, 2024
10-Q
Quarter ended Nov. 3, 2023
10-Q
Quarter ended Aug. 4, 2023
10-Q
Quarter ended May 5, 2023
10-K
Fiscal year ended Feb. 3, 2023
10-Q
Quarter ended Oct. 28, 2022
10-Q
Quarter ended July 29, 2022
10-Q
Quarter ended April 29, 2022
10-K
Fiscal year ended Jan. 28, 2022
10-Q
Quarter ended Oct. 29, 2021
10-Q
Quarter ended July 30, 2021
10-Q
Quarter ended April 30, 2021
10-K
Fiscal year ended Jan. 29, 2021
10-Q
Quarter ended Oct. 30, 2020
10-Q
Quarter ended July 31, 2020
10-Q
Quarter ended May 1, 2020
10-K
Fiscal year ended Jan. 31, 2020
10-Q
Quarter ended Nov. 1, 2019
10-Q
Quarter ended Aug. 2, 2019
10-Q
Quarter ended May 3, 2019
10-K
Fiscal year ended Feb. 1, 2019
10-Q
Quarter ended Nov. 2, 2018
10-Q
Quarter ended Aug. 3, 2018
10-Q
Quarter ended May 4, 2018
10-K
Fiscal year ended Feb. 2, 2018
10-Q
Quarter ended Nov. 3, 2017
10-Q
Quarter ended Aug. 4, 2017
10-Q
Quarter ended May 5, 2017
10-K
Fiscal year ended Feb. 3, 2017
10-Q
Quarter ended Nov. 4, 2016
10-Q
Quarter ended Aug. 5, 2016
10-Q
Quarter ended May 6, 2016
10-K
Fiscal year ended Jan. 29, 2016
10-Q
Quarter ended Oct. 30, 2015
10-Q
Quarter ended July 31, 2015
10-Q
Quarter ended May 1, 2015
10-K
Fiscal year ended Jan. 30, 2015
10-Q
Quarter ended Oct. 31, 2014
10-Q
Quarter ended Aug. 1, 2014
10-Q
Quarter ended May 2, 2014
10-K
Fiscal year ended Jan. 31, 2014
10-Q
Quarter ended Nov. 1, 2013
10-Q
Quarter ended Aug. 2, 2013
PROXIES
DEF 14A
Filed on April 24, 2024
DEF 14A
Filed on April 26, 2023
DEF 14A
Filed on April 27, 2022
DEF 14A
Filed on April 21, 2021
DEF 14A
Filed on April 22, 2020
DEF 14A
Filed on April 24, 2019
DEF 14A
Filed on April 25, 2018
DEF 14A
Filed on April 26, 2017
DEF 14A
Filed on April 27, 2016
DEF 14A
Filed on April 24, 2015
DEF 14A
Filed on April 24, 2014
TABLE OF CONTENTS
Part I Financial InformationItem 1. Financial StatementsNote 1 Business Overview and Summary Of Significant Accounting Policies:Note 2 Earnings Per Share:Note 3 Revenues:Note 4 Pending Acquisition Of Engility:Note 5 Stock-based Compensation:Note 6 Income Taxes:Note 7 Debt Obligations:Note 8 Derivative Instruments Designated As Cash Flow Hedges:Note 9 Changes in Accumulated Other Comprehensive Income By Component:Note 10 Legal Proceedings and Other Commitments and Contingencies:Item 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 3. Defaults Upon Senior SecuritiesItem 4. Mine Safety DisclosuresItem 5. Other InformationItem 6. Exhibits

Exhibits

2.1 Agreement and Plan of Merger, dated September 9, 2018, by and among Science Applications International Corporation, Inc., a Delaware corporation, Engility, a Delaware corporation, and Raptors Merger Sub, Inc., a Delaware corporation. (Pursuant to Item 601(b)(2) of Regulation S-K, the registrant hereby agrees to supplementally furnish to the Securities and Exchange Commission upon request any omitted schedule or exhibit to the Agreement and Plan of Merger.) Incorporated by reference to Exhibit 2.1 to the Companys Current Report on Form 8-K as filed with the SEC on September 10, 2018. 2.2 Voting Agreement dated as of, September 9, 2018, by and among Science Applications International Corporation, Inc., and Engility Holdings, Inc., and with General Atlantic Partners 85, L.P., GAP Coinvestments III, LLC, GAP Coinvestments IV, LLC, GAP Coinvestments CDA, L.P. and GAPCO GmbH & Co. KG and KKR 2006 Fund L.P., KKR Partners III, L.P., OPERF Co-Investment LLC and 8 North America Investor L.P. Incorporated by reference to Exhibit 2.2 to the Companys Current Report on Form 8-K as filed with the SEC on September 10, 2018. 10.1 Term Loan B Incremental Facility Commitment Letter, dated as of September 9, 2018, among Citigroup Global Markets Inc. and Science Applications International Corporation. Incorporated by reference to Exhibit 10.1 to the Companys Current Report on Form 8-K filed with the SEC on September 10, 2018. 10.2 Third Amended and Restated Credit Agreement by and among SAIC, Citibank, as administrative agent and collateral agent, and certain other agents and lenders party thereto, dated October 31, 2018. Incorporated by reference to Exhibit 10.1 to the Companys Current Report on Form 8-K as filed with the SEC on November 5, 2018. 31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.